Investing

Top Analyst Upgrades and Downgrades: BP, BHP Billiton, Goldman Sachs, Halliburton, IBM, Qualcomm, Rockwell Collins, Sirius XM and More

AK Steel Inc. (NYSE: AKS) was raised to Neutral from Sell at Citigroup. The 52-week range is $3.31 to $11.39, and the consensus price target is $9.61. The shares closed on Tuesday at $6.32.

Central Garden and Pet Co. Inc. (NASDAQ: CENT) was started with a Buy rating at Argus with a $44 price target. That compares with a consensus target of $34. The 52-week range for the shares is $15.08 to $37.95. The stock closed Tuesday $37.19.

Energizer Holdings Inc. (NYSE: ENR) was downgraded to Equal Weight from Overweight at Morgan Stanley. The 52-week range is $41.62 to $59.64, and the consensus price target is $57.11. Shares closed Tuesday at $59.49, so this looks like a valuation call.

Entergy Corp. (NYSE: ETR) had stock coverage on the shares resumed at Mizuho with a Neutral rating. The 52-week range for the stock is $66.71 to $82.09, and the consensus price objective is $74.32. The stock closed on Tuesday at $76.89.

Flowserve Inc. (NYSE: FLS) was upgraded to Outperform from Market Perform at Cowen. The 52-week range is $39.13 to $52.50, and the consensus price objective is $50.31. The stock closed Tuesday at $47.70.

Genesee & Wyoming Inc. (NYSE: GWR) was raised to Buy from Neutral at Merrill Lynch. The 52-week range is $42.21 to $80.73, and the consensus price target is $79.09. The shares closed Tuesday at $65.52.

On Deck Capital Inc. (NASDAQ: ONDK) was resumed with a Buy rating at Stifel, and the firm has a $6 price objective. The 52-week range is $3.64 to $8.94, and the consensus price objective is $5.59. The stock closed Tuesday at $4.39.

Royal Bank of Scotland Group PLC (NYSE: RBS) was raised to Neutral from Underweight at JPMorgan. The 52-week range for the shares is $3.91 to $7.60, and the consensus price target was unavailable. The shares close Tuesday at $5.78.

Sirius XM Holdings Inc. (NASDAQ: SIRI) was downgraded to Underweight from Equal Weight at JPMorgan. The 52-week trading range is $3.74 to $5.53. The consensus price target is $5.28. Shares ended the day on Tuesday at $5.06.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was downgraded to Neutral from Outperform at Wedbush. The analyst also lowered the price target to $75 from $80. That compares with a consensus target of $86.75. The 52-week range is $46.52 to $91.35, and the stock closed Tuesday at $60.06, down over 2%.

In case you missed it, here are Tuesday’s top analyst upgrades and downgrades. They included Alibaba, Apple, Match, McDonald’s, Netflix, Checkpoint, Stratasys and many more.